You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
威高股份(01066.HK)年度純利增19.7%至27.23億元 末期息0.079元
格隆匯 03-30 18:00

格隆匯3月30日丨威高股份(01066.HK)公佈,截至2022年12月31日止年度,錄得收入約人民幣136.19億元,較上一年度增長3.1%,公司擁有人應占純利約人民幣27.23億元,較上一年度增長19.7%,擬派末期息每股人民幣0.079元。

2022年度收入較上一年度不計因同一控制下企業合併作出的會計重述收入增長3.6%;不計特殊項目的公司擁有人應占純利約人民幣27.43億元,較上一年度可比數增長13.9%。

年內,臨牀護理業務錄得營業額約為人民幣47.27億元,較去年增長2.0%,憑藉豐富產品組合,彌補了新冠疫情臨牀開放受限所導致的需求下降;集團繼續於該領域市場保持優勢地位。年內,藥品包裝業務錄得營業額約為人民幣21.05億元,較去年增長3.2%。進一步擴大在生物製藥包裝領域的市場影響力,形成廣泛客户基礎。年內,骨科業務營業額約為人民幣18.30億元,較去年下降13.9%。年內,介入業務錄得營業額約為人民幣19.38億元,較去年增長9.3%。主要是美國愛琅公司銷售額增長明顯,美國愛琅產品在中國市場的銷售取得顯着進展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account